Varex Imaging Corporation Q4 2025 Earnings Call Summary

1Key Financial Results and Metrics

Q4 Revenue: $229 million, up 11% year-over-year, at the high end of guidance.

Medical Segment Revenue: $152 million (up 5% YoY).

Industrial Segment Revenue: $77 million (up 25% YoY), marking the highest quarterly contribution in company history.

Non-GAAP Gross Margin: 34%, exceeding guidance and up 130 basis points YoY.

Non-GAAP EPS: $0.37, up from $0.16 YoY.

Full Year Revenue: $845 million, a 4% increase from FY 2024.

Full Year Non-GAAP EPS: $0.90, up from $0.52 YoY.

Cash Position: Ended Q4 with $155 million in cash, down from $213 million YoY due to debt repayment.

Operating Income: $20 million in Q4, with a full-year operating income of $80 million.

2Strategic Updates and Business Highlights

Strong demand observed in the CT market and industrial segments, particularly in security inspection systems.

Continued investment in R&D, with focus on innovative technologies such as photon counting for CT and radiographic detectors from the new facility in India.

Significant progress in the cargo inspection systems business, with over $55 million in orders booked in FY 2025.

Expansion of manufacturing capabilities in India, with the radiographic detector facility ramping up production.

Positive trends in the industrial segment, driven by increased service revenue contributing to higher gross margins.

3Forward Guidance and Outlook

Q1 2026 Revenue Guidance: Expected between $200 million and $215 million.

Non-GAAP EPS Guidance: Anticipated between $0.05 and $0.25.

Overall, the company expects gradual revenue growth in FY 2026, with medical business growth anticipated, especially outside of China, while modeling flat growth in China.

Continued focus on strengthening supply chain resilience and expanding product offerings in emerging markets.

4Bad News, Challenges, or Points of Concern

Debt Levels: Gross debt outstanding at $370 million, with a net debt leverage ratio of approximately 1.8 times adjusted EBITDA.

Tariff Impact: Current tariffs are impacting gross margins by 100 to 150 basis points, with ongoing uncertainty regarding U.S.-China trade relations.

Customer Concentration: Top 10 customers accounted for 52% of revenue, raising concerns about sustainability.

Geopolitical Risks: Ongoing geopolitical tensions and tariff situations may affect future ordering patterns and market stability.

5Notable Q&A Insights

Customer Concentration: Management acknowledged the concentration risk but noted it has been stable over the years.

China Market Dynamics: While customers in China are projecting stronger orders, the company is modeling flat growth for FY 2026 due to ongoing geopolitical uncertainties.

Industrial Segment Performance: Higher margins in the industrial segment were attributed to an increased proportion of service revenue, which is typically more profitable.

R&D Spending: R&D expenses are expected to remain elevated, driven by ongoing investments in growth initiatives, although overall operating expenses are projected to be lower than the previous year.

Future Product Shipments: The new tube factory in India is still about 12-15 months away from production, which may impact future growth and margin improvements. This summary encapsulates the key aspects of Varex Imaging Corporation's Q4 2025 earnings call, providing a clear overview of financial performance, strategic direction, and potential challenges ahead.